Irradiation to the left breast is not associated with a higher risk of cardiac death up to 20 years after treatment, but it is associated with an increased rate of diagnoses of coronary artery disease and myocardial infarction compared with right breast treatment. Radiation therapy-induced perfusion defects may persist or initially may appear 3 to 6 years following radiation therapy in a high percentage of patients. However, these defects were not associated with changes in regional wall motion or ejection fraction. Additional study is needed to determine the clinical relevance of these defects. Effort should be made to minimize incidental irradiation of the heart while maintaining adequate coverage of target volumes. Four-dimensional computed tomography-derived ventilation regions were successfully used as avoidance structures to reduce the dose-volume and dose-function histograms at 5 Gy in all cases. In a subset, there was also a reduction in the F10 and V10 without a change in the V20, suggesting that this technique can be safely used. Respiratory gating may reduce average motion during the course of treatment, but large motion is still possible when delivering gated treatment. Setup uncertainties were on the order of,if not larger than,residual gated motion. The authors recommend careful consideration of all sources of error before reducing margins on the basis of respiratory motion management alone without a strategy for accurate patient setup on a daily basis. Radiation sensitivity can be predicted based on gene expression profiles, and a genomic approach is introduced to the identification of novel molecular markers of radiation sensitivity. Gene expression profiling succeeded to some extent in discriminating groups of patients with and without severe late radiotherapy toxicity. The discriminative power was enhanced by assessment of functionally or structurally related gene sets. While prediction of individual response requires improvement, this study is a step forward in predicting susceptibility to late radiation toxicity. This review introduces the mechanisms of radiation-induced lung injury and summarizes clinical research focused on evaluating changes in biological markers before, during, and after radiation therapy of the thorax. Patients with lower levels of plasma IL-8 before radiation therapy might be at increased risk for developing symptomatic radiation-induced lung injury (SRILI). Further studies are necessary to determine whether IL-8 levels are predictive of SRILI in a prospec- Stereotactic body radiation therapy has a potential role in the management of renal cell carcinoma, either as an alternative to surgery to the primary site or as cytoreductive therapy directed toward metastatic sites, and in the management of selected retroperitoneal tumors.
